Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 23Lymphoma, Non-Hodgkin 21Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Lymphoma, Follicular 21Lymphoma, B-Cell, Marginal Zone 21Leukemia, Lymphocytic, Chronic, B-Cell 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 20Lymphoma, Large-Cell, Immunoblastic 19Lymphoma 19Leukemia, Myeloid, Acute 19Burkitt Lymphoma 19Multiple Myeloma 18Leukemia, Myeloid, Chronic-Phase 18Leukemia, Myeloid, Accelerated Phase 18Leukemia 18Congenital Abnormalities 18Sezary Syndrome 17Neoplasms, Plasma Cell 17Myelodysplastic Syndromes 17Hodgkin Disease 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Myeloproliferative Disorders 16Mycosis Fungoides 16Blast Crisis 16Primary Myelofibrosis 12Lymphoma, Large-Cell, Anaplastic 12Lymphoma, Extranodal NK-T-Cell 12Waldenstrom Macroglobulinemia 11Leukemia, Myelomonocytic, Chronic 11

Interventions

Lymphatic Irradiation 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycoses × Antilymphocyte Serum × Dermatologic × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡